ResMed will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.

BSX carries a Zacks Rank #2 (Buy), while RMD has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 ...

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Resmed RMD has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart Comfort. The company will debut Smart Comfort in early 2026 in a limited U.S.

Independent Analysis of Yu Sleep Reveals How Its Nano-Delivery System and Melatonin-Free Formula Are Redefining Natural Sleep Support in 2025 Unlike generic sleep drops or pills that rely on hormones, ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

A large number of Americans are using PTO to sleep rather than take a vacation, according to a new report. An Amerisleep.com survey of more than 1,200 Americans revealed that 37 percent used vacation ...

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. ResMed Inc. is placed fourth among them. ResMed Inc. (NYSE:RMD) is a leading health technology company ...

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A replay of the earnings webcast will be accessible on ...